Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?

Exclusion Criteria

• •1. Any use of coercive measures according to the Danish law for Mental Health/Psykiatriloven (as defined in "Informationsbekendtgørelsen § 10").
• •2. Fertile females of child-bearing potential who are pregnant, breast-feeding or have the intention of becoming pregnant
• •3. Women who are not willing to use an adequate contraceptive considered as highly effective (IUD or hormonal contraception during the full length of the study
• •4. Impaired hepatic function (plasma liver transaminases \>2 times the upper normal limit)
• •5. Impaired renal function (serum creatinine \>150 μmol/l and/or macroalbuminuria)
• •6. Impaired pancreatic function (acute or chronic pancreatitis and/or plasma amylase \>2 times the upper normal limit)
• •7. Cardiac problems defined as decompensated heart failure (NYHA class III/IV), unstable angina pectoris and/or myocardial infarction within the last 12 months
• •8. Hypertension with systolic blood pressure \>180 mmHg or diastolic blood pressure \>100 mmHg
• •9. Any condition that the investigator feels would interfere with trial participation
• •10. Use of weight-lowering pharmacotherapy within the preceding 3 months
• •11. Type 1 diabetes
• •12. Patients treated with insulin
• •13. Patients treated with other GLP-1 receptor agonist medicines
• •14. Known allergy to liraglutide or any of the ingredients in Saxenda®